Maravai LifeSciences Ownership | Who Owns Maravai LifeSciences?


OverviewForecastRevenueFinancialsChartTranscripts

Maravai LifeSciences Ownership Summary


Maravai LifeSciences is owned by 96.40% institutional investors, 1.20% insiders, and 2.40% retail investors. Gtcr is the largest institutional shareholder, holding 14.23% of MRVI shares. Canada Life US Small-Mid Cap Growth A is the top mutual fund, with 3.22% of its assets in Maravai LifeSciences shares.

MRVI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMaravai LifeSciences96.40%1.20%2.40%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Gtcr20.15M14.23%$109.82M
Vanguard group11.82M8.35%$64.43M
12 west capital management lp11.59M8.19%$63.17M
Blackrock9.73M7.35%$69.66M
Blackrock funding, inc. /de9.78M6.91%$53.29M
Braidwell lp8.35M5.90%$45.53M
Mackenzie financial6.18M4.37%$31.41M
Alyeska investment group5.33M3.76%$29.05M
Massachusetts financial services co /ma/4.66M3.29%$25.42M
Jpmorgan chase4.25M3.00%$23.17M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Gtcr20.15M10.56%$109.82M
12 west capital management lp11.59M6.62%$63.17M
Braidwell lp8.35M1.35%$45.53M
Penderfund capital management580.30K0.98%$4.55M
Alpine peaks capital, lp204.00K0.91%$1.11M
Pier capital1.13M0.88%$6.15M
Sivik global healthcare140.00K0.40%$763.00K
Point72 (difc)1.56M0.31%$8.48M
Centerbook partners lp811.93K0.26%$4.42M
Parkman healthcare partners350.00K0.25%$1.91M

Top Buyers

HolderShares% AssetsChange
Blackrock9.73M0.00%3.31M
Alyeska investment group5.33M0.11%3.16M
Marshall wace, llp2.78M0.02%2.76M
Ubs group1.95M0.00%1.72M
Massachusetts financial services co /ma/4.66M0.01%1.06M

Top Sellers

HolderShares% AssetsChange
Point72 europe (london) llp---2.47M
12 west capital management lp11.59M6.62%-2.42M
Millennium management1.91M0.01%-2.42M
First trust advisors lp---2.40M
Portolan capital management---1.79M

New Positions

HolderShares% AssetsChangeValue
Centerbook partners lp811.93K0.26%811.93K$4.42M
Penderfund capital management580.30K0.98%580.30K$4.55M
Parkman healthcare partners350.00K0.25%350.00K$1.91M
Wealthfront advisers191.90K0.06%191.90K$19.03M
Hrt financial lp153.68K0.00%153.68K$837.00K

Sold Out

HolderChange
Sjs investment consulting-2.00
Jfs wealth advisors-5.00
Assetmark-21.00
Financial network wealth advisors-29.00
Systm wealth solutions-44.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024172-21.82%136,455,890-5.23%960.93%81-27.68%59-13.24%
Sep 30, 20242206.80%143,991,590-2.29%1010.82%113-68-1.45%
Jun 30, 2024206-3.74%147,373,4478.71%1111.06%1131.80%69-2.82%
Mar 31, 2024214-4.89%135,569,9950.60%1020.98%111-18.98%7112.70%
Dec 31, 20232258.70%134,766,3520.18%1020.98%13710.48%6312.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Canada Life US Small-Mid Cap Growth A4.57M3.22%-
Canada Life US Small-Mid Cap Growth F4.57M3.18%-
Vanguard US Total Market Shares ETF3.94M2.74%547.00K
Vanguard Total Stock Mkt Idx Inv3.78M2.66%-
Vanguard Small Cap Index3.08M2.17%2.52K
iShares Russell 2000 ETF2.97M2.07%-25.74K
Columbia Acorn Inst2.26M1.57%-
Glenmede Small Cap Equity Adv2.03M1.43%-14.85K
Glenmede Small Cap Equity2.03M1.43%-14.85K
MFS New Discovery Value I2.01M1.42%-28.80K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 31, 2025ORESHACK KURT General CounselSell$125.75K
Nov 12, 2024DeFord John A-Buy$100.63K
Nov 11, 2024HULL CARL See RemarksBuy$987.00K
May 28, 2024GTCR INVESTMENT XI LLC Sell$97.57M
Nov 25, 2020HULL CARL Chief Executive OfficerBuy$942.90K

Insider Transactions Trends


DateBuySell
2025 Q1-1
2024 Q42-
2024 Q3--
2024 Q2-1
2024 Q1--

MRVI Ownership FAQ


Who Owns Maravai LifeSciences?

Maravai LifeSciences shareholders are primarily institutional investors at 96.40%, followed by 1.20% insiders and 2.40% retail investors. The average institutional ownership in Maravai LifeSciences's industry, Biotech Stocks , is 68.48%, which Maravai LifeSciences exceeds.

Who owns the most shares of Maravai LifeSciences?

Maravai LifeSciences’s largest shareholders are Gtcr (20.15M shares, 14.23%), Vanguard group (11.82M shares, 8.35%), and 12 west capital management lp (11.59M shares, 8.19%). Together, they hold 30.77% of Maravai LifeSciences’s total shares outstanding.

Does Blackrock own Maravai LifeSciences?

Yes, BlackRock owns 7.35% of Maravai LifeSciences, totaling 9.73M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 69.66M$. In the last quarter, BlackRock increased its holdings by 3.31M shares, a 51.67% change.

Who is Maravai LifeSciences’s biggest shareholder by percentage of total assets invested?

Gtcr is Maravai LifeSciences’s biggest shareholder by percentage of total assets invested, with 10.56% of its assets in 20.15M Maravai LifeSciences shares, valued at 109.82M$.

Who is the top mutual fund holder of Maravai LifeSciences shares?

Canada Life US Small-Mid Cap Growth A is the top mutual fund holder of Maravai LifeSciences shares, with 3.22% of its total shares outstanding invested in 4.57M Maravai LifeSciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools